He Y, Lin Y, Song J, Song M, Nie X, Sun H
Cell Commun Signal. 2025; 23(1):125.
PMID: 40055721
PMC: 11889974.
DOI: 10.1186/s12964-025-02121-2.
Wen J, Li A, Wang Z, Guo X, Zhang G, Litzow M
Front Pharmacol. 2025; 16:1536388.
PMID: 40051569
PMC: 11882591.
DOI: 10.3389/fphar.2025.1536388.
Shen C, Wang W, Wei D, Yang X, Jiang C, Sheng Y
BMC Pulm Med. 2025; 25(1):98.
PMID: 40022042
PMC: 11869717.
DOI: 10.1186/s12890-025-03555-7.
Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J
Bone Res. 2025; 13(1):27.
PMID: 40000618
PMC: 11861620.
DOI: 10.1038/s41413-024-00398-6.
Li M, Hu Y, Wu X, Tong J, Tao J, Tang A
Biol Trace Elem Res. 2025; .
PMID: 39912999
DOI: 10.1007/s12011-025-04525-0.
Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells.
Zhang Z, Xu H, He J, Hu Q, Liu Y, Xu Z
Cell Death Dis. 2025; 16(1):28.
PMID: 39827156
PMC: 11743205.
DOI: 10.1038/s41419-025-07330-8.
N6-methyladenosine RNA modification regulates the transcription of SLC7A11 through KDM6B and GATA3 to modulate ferroptosis.
Zhang H, Yi C, Li J, Lu Y, Wang H, Tao L
J Biomed Sci. 2025; 32(1):8.
PMID: 39800682
PMC: 11726933.
DOI: 10.1186/s12929-024-01100-y.
Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis.
Liang J, Chen M, Yan G, Hoa P, Wei S, Huang H
Clin Exp Med. 2025; 25(1):29.
PMID: 39753901
PMC: 11698805.
DOI: 10.1007/s10238-024-01550-6.
Mechanisms of postischemic cardiac death and protection following myocardial injury.
Mastoor Y, Murphy E, Roman B
J Clin Invest. 2025; 135(1).
PMID: 39744953
PMC: 11684816.
DOI: 10.1172/JCI184134.
Decoding ferroptosis: transforming orthopedic disease management.
Huo G, Lin Y, Liu L, He Y, Qu Y, Liu Y
Front Pharmacol. 2024; 15:1509172.
PMID: 39712490
PMC: 11659002.
DOI: 10.3389/fphar.2024.1509172.
GLP-1 Receptor Agonists Alleviate Diabetic Kidney Injury via β-Klotho-Mediated Ferroptosis Inhibition.
Tian S, Zhou S, Wu W, Lin Y, Wang T, Sun H
Adv Sci (Weinh). 2024; 12(4):e2409781.
PMID: 39630101
PMC: 11775532.
DOI: 10.1002/advs.202409781.
Identification of key ferroptosis‑related biomarkers in Kawasaki disease by clinical and experimental validation.
Yan R, Chen S, Lang X, Liu J, Zhou T
Biomed Rep. 2024; 22(1):16.
PMID: 39624783
PMC: 11609609.
DOI: 10.3892/br.2024.1894.
[Research progress of iron metabolism and ferroptosis in myeloid neoplasms].
Wang Y, Feng W, Wang F, Min J
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(6):735-746.
PMID: 39608794
PMC: 11736352.
DOI: 10.3724/zdxbyxb-2024-0211.
Differential expression of ferroptosis-related proteins in urinary exosomes: potential indicators for monitoring acute gout attack.
Wang J, Lin Y, Liu N, Hu M, Zhang M
Front Mol Biosci. 2024; 11:1476631.
PMID: 39606034
PMC: 11599738.
DOI: 10.3389/fmolb.2024.1476631.
Ferroptosis: mechanisms and therapeutic targets.
Zhou Q, Meng Y, Le J, Sun Y, Dian Y, Yao L
MedComm (2020). 2024; 5(12):e70010.
PMID: 39568772
PMC: 11577302.
DOI: 10.1002/mco2.70010.
Unveiling the Molecular Links Between Atrial Fibrillation and Atherosclerosis: Insights into Shared Pathogenesis and Ferroptosis Diagnostic Biomarkers.
Xu B, Li H, Chen H, Teng D, Gong L, Zhong L
J Inflamm Res. 2024; 17:8813-8830.
PMID: 39559400
PMC: 11570537.
DOI: 10.2147/JIR.S488288.
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.
Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F
Signal Transduct Target Ther. 2024; 9(1):271.
PMID: 39396974
PMC: 11486532.
DOI: 10.1038/s41392-024-01969-z.
Current status and prospects of MOFs loaded with HO-related substances for ferroptosis therapy.
Deng Y, Huang S, Jiang G, Zhou L, Nezamzadeh-Ejhieh A, Liu J
RSC Med Chem. 2024; 15(9):2996-3016.
PMID: 39309362
PMC: 11411616.
DOI: 10.1039/d4md00261j.
Mechanisms of ferroptosis and glucagon-like peptide-1 receptor agonist in post-percutaneous coronary intervention restenosis.
Wang M, Wang L, Sun H, Yuan H, Li Y
Mol Cell Biochem. 2024; 480(3):1465-1480.
PMID: 39283562
DOI: 10.1007/s11010-024-05118-6.
Broadening horizons: the role of ferroptosis in polycystic ovary syndrome.
Wang M, Zhang B, Ma S, Xu Y, Zhao D, Zhang J
Front Endocrinol (Lausanne). 2024; 15:1390013.
PMID: 39157678
PMC: 11327064.
DOI: 10.3389/fendo.2024.1390013.